NCT00381628View on ClinicalTrials.gov

Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Cystic Fibrosis
Interventions
PROCEDURE

epithelial cells and blood lymphocyte extraction

Nasal curettage will be performed from each nostril to obtain nasal epithelial cells. Venipuncture will be performed and up to 60-ml of blood will be obtained from which neutrophils will be isolated.

Trial Locations (1)

44106

Rainbow Babies and Children's Hospital, Cleveland

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

University Hospitals Cleveland Medical Center

OTHER

NCT00381628 - Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations | Biotech Hunter | Biotech Hunter